{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Hereditary haemorrhagic telangiectasia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_clopidogrel",
          "name": "Clopidogrel"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_ibuprofen",
          "name": "Ibuprofen"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_rivaroxaban",
          "name": "Rivaroxaban"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_apixaban",
          "name": "Apixaban"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_enoxaparin",
          "name": "Enoxaparin"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_dabigatran",
          "name": "Dabigatran"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_heparin",
          "name": "Heparin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_fondaparinux",
          "name": "Fondaparinux"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_nsaids",
          "name": "NSAIDs"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_phenprocoumon",
          "name": "Phenprocoumon"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 4
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "target_cox",
          "type": "Target",
          "label": "Cyclooxygenase (COX)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_factors",
          "type": "Target",
          "label": "Coagulation Factors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_hemostasis",
          "type": "Pathway",
          "label": "Hemostasis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_anticoagulation",
          "type": "Pathway",
          "label": "Anticoagulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_vascular",
          "type": "Phenotype",
          "label": "Vascular Complications",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_bleeding",
          "type": "Phenotype",
          "label": "Bleeding Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_aspirin",
          "target": "target_cox",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Aspirin inhibits COX enzymes, which are involved in hemostasis."
        },
        {
          "source": "drug_warfarin",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Warfarin modulates coagulation factors, affecting bleeding risk."
        },
        {
          "source": "drug_clopidogrel",
          "target": "target_cox",
          "relation": "acts_on",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "Clopidogrel inhibits platelet activation by targeting COX."
        },
        {
          "source": "drug_ibuprofen",
          "target": "target_cox",
          "relation": "acts_on",
          "weight": 0.76,
          "agent": "Proponent",
          "rationale": "Ibuprofen inhibits COX, impacting hemostatic balance."
        },
        {
          "source": "drug_rivaroxaban",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Rivaroxaban inhibits specific coagulation factors."
        },
        {
          "source": "drug_apixaban",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.73,
          "agent": "Proponent",
          "rationale": "Apixaban directly inhibits coagulation factors."
        },
        {
          "source": "drug_enoxaparin",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Enoxaparin inhibits factors in the coagulation cascade."
        },
        {
          "source": "drug_dabigatran",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.68,
          "agent": "Proponent",
          "rationale": "Dabigatran inhibits thrombin, a key factor in coagulation."
        },
        {
          "source": "drug_heparin",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.66,
          "agent": "Proponent",
          "rationale": "Heparin prevents thrombus formation through factor inhibition."
        },
        {
          "source": "drug_fondaparinux",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Fondaparinux inhibits anticoagulation factors."
        },
        {
          "source": "drug_nsaids",
          "target": "target_cox",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "NSAIDs often inhibit COX, posing bleeding risks."
        },
        {
          "source": "target_cox",
          "target": "pathway_hemostasis",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "COX activity is essential for normal hemostasis."
        },
        {
          "source": "target_factors",
          "target": "pathway_anticoagulation",
          "relation": "involved_in",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "Coagulation factors are critical in the anticoagulation pathway."
        },
        {
          "source": "pathway_hemostasis",
          "target": "phenotype_bleeding",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Disruption in hemostasis leads to bleeding disorders."
        },
        {
          "source": "pathway_anticoagulation",
          "target": "phenotype_bleeding",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Altered anticoagulation can increase bleeding risks."
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "使用 Aspirin、Warfarin、Clopidogrel 等药物可导致出血性并发症",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "抗凝血药物影响正常止血过程，可能加重遗传性出血性毛细血管扩张症",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物有潜在的出血风险，尤其在遗传性出血性毛细血管扩张症患者中"
    ],
    "uncertainties": [],
    "next_focus_for_pi": [
      "进一步研究药物对特定人群的具体影响"
    ]
  }
}